Published online before print February 13, 2003, doi: 10.1161/01.RES.0000061570.83105.52
© 2003 American Heart Association, Inc.
Integrative Physiology |
Vasomodulation by Skeletal Muscle–Derived Nitric Oxide Requires 
-Syntrophin–Mediated Sarcolemmal Localization of Neuronal Nitric Oxide Synthase
From the Departments of Internal Medicine (G.D.T.) and Pediatrics (P.W.S., I.S.Y.), University of Texas Southwestern Medical Center, Dallas, Tex, and Department of Physiology and Biophysics (S.C.F., M.E.A.), University of Washington, Seattle, Wash.
Correspondence to Gail D. Thomas, Department of Internal Medicine, Division of Hypertension, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-8586. E-mail gail.thomas{at}utsouthwestern.edu
Neuronal nitric oxide synthase (nNOS) is abundantly expressed in skeletal muscle where it associates with the dystrophin complex at the sarcolemma by binding to the PDZ domain of 
-syntrophin. Nitric oxide (NO) produced by skeletal muscle nNOS is proposed to regulate blood flow in exercising muscle by diffusing from the skeletal muscle fibers to the nearby microvessels where it attenuates -adrenergic vasoconstriction. In the present study, we hypothesized that sarcolemmal localization of nNOS is a critical determinant of the vasoregulatory effect of skeletal muscle–derived NO. To test this hypothesis, we performed experiments in -syntrophin null mice and in transgenic mice expressing a mutated -syntrophin lacking the PDZ domain (
PDZ), both of which are characterized by reduced sarcolemmal nNOS. We found that modulation of -adrenergic vasoconstriction was greatly impaired in the contracting muscles of the -syntrophin null mice and transgenic PDZ mice compared with wild-type mice and transgenic mice expressing full-length -syntrophin. These in vivo mouse studies highlight the functional importance of appropriate membrane targeting of nNOS by the dystrophin-associated protein -syntrophin and may have implications for the development of potential gene therapy strategies to treat muscular dystrophy or other muscle-related diseases.
Key Words: -adrenergic • muscle contraction • blood flow • -syntrophin • PDZ domain
This article has been cited by other articles:
 |
|
 |
|
  W. Song, H.-B. Kwak, J.-H. Kim, and J. M. Lawler Exercise Training Modulates the Nitric Oxide Synthase Profile in Skeletal Muscle From Old Rats J Gerontol A Biol Sci Med Sci, May 1, 2009; 64A(5): 540 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Da Silva-Azevedo, S. Jahne, C. Hoffmann, D. Stalder, M. Heller, A. R. Pries, A. Zakrzewicz, and O. Baum Up-regulation of the peroxiredoxin-6 related metabolism of reactive oxygen species in skeletal muscle of mice lacking neuronal nitric oxide synthase J. Physiol., February 1, 2009; 587(3): 655 - 668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Adams, Y. Tesch, J. M. Percival, D. E. Albrecht, J. I. Conhaim, K. Anderson, and S. C. Froehner Differential targeting of nNOS and AQP4 to dystrophin-deficient sarcolemma by membrane-directed {alpha}-dystrobrevin J. Cell Sci., January 1, 2008; 121(1): 48 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ito, S. Kimura, S. Ozasa, M. Matsukura, M. Ikezawa, K. Yoshioka, H. Ueno, M. Suzuki, K. Araki, K.-i. Yamamura, et al. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice Hum. Mol. Genet., July 15, 2006; 15(14): 2266 - 2275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Chen, C. Hague, R. A. Hall, and K. P. Minneman Syntrophins Regulate {alpha}1D-Adrenergic Receptors through a PDZ Domain-mediated Interaction J. Biol. Chem., May 5, 2006; 281(18): 12414 - 12420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Judge, M. Haraguchiln, and J. S. Chamberlain Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex J. Cell Sci., April 15, 2006; 119(8): 1537 - 1546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Jagnandan, W. C. Sessa, and D. Fulton Intracellular location regulates calcium-calmodulin-dependent activation of organelle-restricted eNOS Am J Physiol Cell Physiol, October 1, 2005; 289(4): C1024 - C1033. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Heydemann and E. M. McNally Regenerating More Than Muscle in Muscular Dystrophy Circulation, November 23, 2004; 110(21): 3290 - 3292. [Full Text] [PDF]
|
|
|
|
|
|
S. Straino, A. Germani, A. Di Carlo, D. Porcelli, R. De Mori, A. Mangoni, M. Napolitano, F. Martelli, P. Biglioli, and M. C. Capogrossi Enhanced Arteriogenesis and Wound Repair in Dystrophin-Deficient mdx Mice Circulation, November 23, 2004; 110(21): 3341 - 3348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Adams, N. Kramarcy, T. Fukuda, A. G. Engel, R. Sealock, and S. C. Froehner Structural Abnormalities at Neuromuscular Synapses Lacking Multiple Syntrophin Isoforms J. Neurosci., November 17, 2004; 24(46): 10302 - 10309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shiao, A. Fond, B. Deng, M. Wehling-Henricks, M. E. Adams, S. C. Froehner, and J. G. Tidball Defects in neuromuscular junction structure in dystrophic muscle are corrected by expression of a NOS transgene in dystrophin-deficient muscles, but not in muscles lacking {alpha}- and {beta}1-syntrophins Hum. Mol. Genet., September 1, 2004; 13(17): 1873 - 1884. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Thomas and S. S. Segal Neural control of muscle blood flow during exercise J Appl Physiol, August 1, 2004; 97(2): 731 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Lapidos, R. Kakkar, and E. M. McNally The Dystrophin Glycoprotein Complex: Signaling Strength and Integrity for the Sarcolemma Circ. Res., April 30, 2004; 94(8): 1023 - 1031. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Wray, P. J. Fadel, M. L. Smith, P. Raven, and M. Sander Inhibition of {alpha}-adrenergic vasoconstriction in exercising human thigh muscles J. Physiol., March 1, 2004; 555(2): 545 - 563. [Abstract] [Full Text] [PDF]
|
|